#reinfection

A concern most hepatitis C patients have after treatment is the possibility of Hep C coming back.

Long-lived memory immune cells continue to provide protection even after antibody levels drop.

A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.

Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.

Consistent use of medication-assisted treatment for opioid use disorder can apparently reduce this risk.

Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.

A study of gay and bi men with HIV in Australia who had been cured of hep C found they associated hep C with injection drug use.

A study conducted in Australia treated people attending a syringe services program.

Researchers used mathematical modeling to analyze the benefits of treating with buprenorphine/naloxone on-site.

HIV-positive men who have sex with men in Western nations historically have a significant risk of contracting hepatitis C through sex.

A look at personal hygiene instruments that may transmit hepatitis C.

Using opioid medication treatment such as methadone appears to lower this risk.

This would hold true even if the hepatitis C vaccine did not provide sterilizing immunity.

Research suggests that individuals receiving opioid replacement therapy have a better chance of beating hep C through this method.

Few people saw their liver disease progress, and there were scant numbers of relapses more than 12 weeks posttreatment in a large study.

Researchers from a German cohort found that the reinfection rate for men who have sex with men was almost 10 percent per year.